Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fangshen zhiyang granule
- Development stage
- Unknown
- Lead developer
- Shandong Wohua Pharmaceutical
- Administration
- Oral
01
Overview
Fangshen Zhiyang Granule is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Shandong Wohua Pharmaceutical Polytron Technologies. It is an oral granule indicated for the treatment of pruritus and skin itching. The product is based on traditional herbal principles, likely incorporating ingredients such as Saposhnikovia divaricata (Fangfeng) and Sophora flavescens (Kushen) to address the underlying TCM patterns of wind and heat that manifest as dermatological irritation. It is currently approved and commercially available in the Chinese market.
- Brand names
- 防参止痒颗粒
- Other names
- Fangshen Zhiyang Keli
Beyond the preview
Go deeper on fangshen zhiyang granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fangshen zhiyang granule.